Related Experiment Videos
Experimental diabetes and platelet aggregation in the rat.
Research Communications in Chemical Pathology and Pharmacology
|August 1, 1983
Summary
Diabetic rats showed increased platelet aggregation and serotonin release. Insulin treatment did not normalize these heightened platelet responses in diabetes.
Area of Science:
- Endocrinology
- Hematology
- Pharmacology
Background:
- Diabetes mellitus is a metabolic disorder associated with cardiovascular complications.
- Platelet hyperreactivity is implicated in thrombotic events in diabetic patients.
- Alloxan is a diabetogenic agent used to induce experimental diabetes in animal models.
Purpose of the Study:
- To investigate the effect of alloxan-induced diabetes on platelet aggregation and serotonin release in rats.
- To evaluate the impact of insulin treatment on platelet function in diabetic rats.
Main Methods:
- Male Sprague-Dawley rats were induced with diabetes using alloxan.
- Platelet aggregation was measured in response to adenosine diphosphate (ADP) and thrombin.
- Serotonin release was assessed following thrombin-stimulated platelet aggregation.
- Insulin (protamine-zinc insulin) was administered to a subset of diabetic rats.
Main Results:
- Platelets from diabetic rats exhibited enhanced aggregation in response to ADP and thrombin compared to control rats.
- Insulin treatment did not restore platelet responsiveness to control levels in diabetic rats.
- Thrombin-stimulated platelets from diabetic rats showed significantly greater serotonin release than those from control rats.
Conclusions:
- Alloxan-induced diabetes in rats leads to platelet hyperaggregability and increased serotonin release.
- Insulin therapy, at the dose studied, does not normalize the altered platelet function in experimental diabetes.
- These findings suggest a potential prothrombotic state in diabetes, independent of glycemic control via insulin.